Efficacy and safety of steroid‐sparing strategy in the treatment of AIHA associated with KSHV/HHV‐8 positive multicentric Castleman disease
HemaSphere · 2026-04 · 10 (4)
DOI: 10.1002/hem3.70304 ↗Kurz gefasst
Leserbrief in der Zeitschrift HemaSphere, online erschienen am 08.04.2026. Verfasst von Yannick Dieudonné und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Internal Medicine National Reference Center for Systemic Autoimmune Diseases (RESO), CHU Strasbourg Strasbourg …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical Immunology and Internal Medicine National Reference Center for Systemic Autoimmune Diseases (RESO), CHU Strasbourg Strasbourg France.
- Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute Université Paris Cité Paris France.
- Department of Hematology Centre Hospitalo-Universitaire d'Amiens Amiens France.
- Department of Internal Medicine, Hôpital Cochin Université Paris Cité Paris France.
- Department of Intensive Care CHU Grenoble-Alpes Grenoble France.
- Department of Hematology Centre Hospitalier Sud-Francilien Corbeil-Essonnes France.
ORCID-Profile: Romain Stammler, Robin Noel, David Boutboul
Zitieren
APA
Dieudonné, Y., Gourguechon, C., Stammler, R., Delestre, F., Sorin, B., Dunogué, B., Dumas, G., Fouquet, G., Ronchetti, A. M., Paule, R., Meliani, P., Pansu, N., Buzele, R., Noel, R., Fadlallah, J., Malphettes, M., Corvilain, E., Meignin, V., Guillaud, C., …, & Boutboul, D. (2026). Efficacy and safety of steroid‐sparing strategy in the treatment of AIHA associated with KSHV/HHV‐8 positive multicentric Castleman disease. HemaSphere, 10(4). https://doi.org/10.1002/hem3.70304
Vancouver
Dieudonné Y, Gourguechon C, Stammler R, Delestre F, Sorin B, Dunogué B, et al. Efficacy and safety of steroid‐sparing strategy in the treatment of AIHA associated with KSHV/HHV‐8 positive multicentric Castleman disease. HemaSphere. 2026;10(4). doi:10.1002/hem3.70304
BibTeX
@article{Dieudonn2026,
author = {Dieudonné, Yannick and Gourguechon, Clément and Stammler, Romain and Delestre, Florence and Sorin, Boris and Dunogué, Bertrand and Dumas, Guillaume and Fouquet, Guillemette and Ronchetti, Anne-Marie and Paule, Romain and Meliani, Pascal and Pansu, Nathalie and Buzele, Rodolphe and Noel, Robin and Fadlallah, Jehane and Malphettes, Marion and Corvilain, Emilie and Meignin, Véronique and Guillaud, Constance and Dossier, Antoine and Dion, Jérémie and Gérard, Laurence and Oksenhendler, Eric and Galicier, Lionel and Boutboul, David},
title = {Efficacy and safety of steroid‐sparing strategy in the treatment of AIHA associated with KSHV/HHV‐8 positive multicentric Castleman disease},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {4},
doi = {10.1002/hem3.70304}
}
EUVIMED